Logo

Ingenium Acquires Two Patents from Incyte

May 12, 2004

NEW YORK, May 12 (GenomeWeb News) - Ingenium Pharmaceuticals has acquired two patents relating to generating rodent models from Incyte, the company said today.

 

The patents, US patent No. 5,994,075 and US patent No. 6,015,670, enable Ingenium to provide mouse and rat models developed using its Ingenotyping technology to partners in the US. Previously, Munich-based Ingenium held a license to the patents.

Breaking News
The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.